Bosh sahifaRGEN • NASDAQ
add
Repligen Corp
126,44 $
Seans yopilganidan keyin:(0,00%)0,00
126,44 $
Yopilgan:1-iyl, 16:30:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
124,38 $
Kunlik diapazon
123,10 $ - 131,43 $
Yillik diapazon
102,97 $ - 182,06 $
Bozor kapitalizatsiyasi
7,10 mlrd USD
Oʻrtacha hajm
773,18 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 169,17 mln | 10,44% |
Joriy xarajat | 81,92 mln | 13,50% |
Sof foyda | 5,83 mln | 76,88% |
Sof foyda marjasi | 3,45 | 60,47% |
Har bir ulushga tushum | 0,39 | 39,29% |
EBITDA | 28,16 mln | 27,61% |
Amaldagi soliq stavkasi | 26,60% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 697,23 mln | -10,68% |
Jami aktivlari | 2,85 mlrd | -0,05% |
Jami passivlari | 866,66 mln | -2,41% |
Umumiy kapital | 1,99 mlrd | — |
Tarqatilgan aksiyalar | 56,18 mln | — |
Narxi/balansdagi bahosi | 3,52 | — |
Aktivlardan daromad | 0,83% | — |
Kapitaldan daromad | 0,89% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 5,83 mln | 76,88% |
Operatsiyalardan naqd pul | 15,00 mln | -66,44% |
Sarmoyadan naqd pul | -74,11 mln | -786,25% |
Moliyadan naqd pul | -5,03 mln | 43,95% |
Naqd pulning sof oʻzgarishi | -60,13 mln | -305,25% |
Boʻsh pul | 31,05 mln | -34,31% |
Haqida
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
CEO
Tashkil etilgan
1981
Sayt
Xodimlar soni
1 778
